Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Multicenter, open-label, randomized, controlled parallel-group study to assess discontinuation rates, bleeding patterns, user satisfaction and adverse event profile of LCS12 in comparison to etonorgestrel subdermal implant over 12 months of use in women 18 to 35 years of age
Levonorgestrel
13363
NCT01397097
Contraception
Phase 3
 
December 2016

Powered by ideaPoint, Inc.